Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials

BACKGROUND: Dose-dense chemotherapy is a widely accepted regimen for high-risk breast cancer patients. However, conflicting survival benefits of pure dose-dense chemotherapy have been reported in different randomized controlled trials (RCTs). This meta-analysis aimed to further assess the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wenqi, Chen, Shizhe, Xu, Faliang, Zeng, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046095/
https://www.ncbi.nlm.nih.gov/pubmed/30007402
http://dx.doi.org/10.1186/s12957-018-1424-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046095/
https://www.ncbi.nlm.nih.gov/pubmed/30007402
http://dx.doi.org/10.1186/s12957-018-1424-4

Ejemplares similares